U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944522) titled 'A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease' on April 07.
Brief Summary: Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease (PD).
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Parkinsons Disease (PD)
Intervention:
BIOLOGICAL: bemdaneprocel
Investigational cell therapy comprising midbrain dopaminergic neuron progenitors derived from human embryonic stem cells
PROCEDURE: Sham surgery
Sham surgery wil...